Showing results (1831-1840 of 2,286) with videos related to
Sort By:
Pageof 229
Leukemia|March 12, 2016
Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive RasJ Akutagawa, T Q Huang, I Epstein, et al.Ophthalmic Epidemiology|July 23, 2021
Refractive Error Findings in Students Who Failed School-based Vision ScreeningXinxing Guo, Angeline M Nguyen, Hursuong Vongsachang, et al.The Oncologist|April 19, 2018
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant GliomaMary Lou Affronti, Jennifer Gamboa Jackman, Frances McSherry, et al.Cytotherapy|November 26, 2010
Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horsesDanielle D Carrade, Sean D Owens, Larry D Galuppo, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|February 26, 2021
Priority Areas for Adolescent Health MeasurementRegina Guthold, Ann-Beth Moller, Emmanuel Adebayo, et al.Cancer|May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case studyI Cokgor, G Akabani, H S Friedman, et al.Cancer|April 30, 2009
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.Journal of Clinical Psychopharmacology|May 18, 2010
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study reportDiane Warden, Madhukar H Trivedi, Stephen R Wisniewski, et al.Plos One|October 8, 2011
A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individualsJoshua L Roffman, Adam Z Nitenson, Yigal Agam, et al.Pageof 229